To identify predictors of the presence of coronary artery disease (CAD) in patients with planned surgery for aortic aneurysms, we reviewed clinical profiles and angiography records of 191 patients with aortic aneurysms (34 thoracic, 137 abdominal, and 20 thoracoabdominal; 162 men; mean age, 75.2 + 7.7 years). The incidence of CAD was 38.7% among all the patients. Patients with CAD had significantly low levels of high-density lipoprotein cholesterol (HDL-C) as compared with patients without CAD (45 + 9 vs 51 + 13 mg/dL; P ¼ .009). Multivariate analysis showed that only low HDL-C levels were associated with the presence of CAD (adjusted odds ratio, 0.946; 95% confidence interval, 0.911-0.983; P ¼ .004). The optimal cutoff level of HDL-C to predict CAD was 47.50 mg/dL. The CAD is common in patients with aortic aneurysms, and low levels of HDL-C are independently associated with the presence of CAD.
Introduction
Aortic aneurysms may represent systemic atherosclerosis and are associated with common risk factors for cardiovascular disease. 1 A high incidence of coronary artery disease (CAD) has been reported in patients with aortic aneurysms, with the prevalence as high as 30% to 70%. 2, 3 The high comorbidity indicates an etiological association between CAD and abdominal aortic aneurysms (AAAs). Large-scale clinical studies to identify perioperative risks of noncardiac surgery have enabled the development of risk indices/scores 4 that indicate an increase in perioperative cardiovascular events in patients with CAD. Indeed, a previous report has shown that the presence of CAD is associated with late mortality and morbidity after abdominal aortic aneurysmectomy. 5 Thus, preoperative diagnosis of CAD in patients with aortic aneurysms is essential; however, the predictors of comorbid CAD have not been fully investigated. In this study, we examined the incidence and predictors of CAD in patients with planned surgery for aortic aneurysms.
Materials and Methods Patients
The study population comprised 191 patients who were admitted for planned surgery for thoracic aortic aneurysms (TAAs) and/or AAAs between January 2006 and December 2009. Because of the high incidence of CAD accompanying aortic aneurysms, coronary angiography was performed in all perioperative patients with aneurysm, regardless of the patient's symptoms, after informed consent was obtained. Patient's background details and laboratory examination results on admission were obtained retrospectively from medical records. Hypertension was defined as a systolic blood pressure (BP) at rest of >140 mm Hg and/ or a diastolic BP at rest of >90 mm Hg on admission or current treatment with antihypertensive agents. Smoking status was defined as a history of smoking or the smoking of at least 1 cigarette/d at present. Body mass index was calculated, and diabetes was evaluated by the levels of hemoglobulin A 1c (HbA 1c ). Patients were excluded if they had been given a previous diagnosis of angiographically significant CAD, history of percutaneous coronary intervention or coronary artery bypass grafting, and/or symptomatic angina. No patients were enrolled without obtaining informed consent for coronary angiography.
Definition of CAD
Coronary angiography was mostly performed via the radial artery. Diagnoses were made by at least 2 experienced cardiologists. The CAD was considered significant in the event of an angiographic luminal stenosis of !75% of the epicardial coronary artery or a stenosis of !50% of the left main trunk.
Indication for Coronary Revascularization
Procedures for coronary revascularization were performed following the guidelines for elective percutaneous coronary intervention in patients with stable CAD. The Japanese guidelines are in accordance with those published by the Task Force on Myocardial Revascularization of the European Society of Cardiology and the European Association for Cardio-Thoracic Surgery; European Association for Percutaneous Cardiovascular Interventions. 6 
Surgical Treatment of Aortic Aneurysm
Indications and strategies for surgical intervention of aortic aneurysms were dependent either on the size of aneurysm or on the risk of rupture. In general, patients with a TAA of >6 cm in diameter or an AAA of >5 cm in diameter were recruited. In addition, patients with high-risk aneurysms with a rapid increase in size or that were saccular were also enrolled before surgical intervention. Placement of endovascular stent grafts was recommended in patients at high risk of open aortic surgery.
Statistical Analyses
Data are presented as mean + standard deviation for continuous variables and as numbers and percentages for categorical variables. Continuous variables were compared using the nonpaired t test in normal distribution or Mann-Whitney U test in nonnormal distribution. Categorical variables were compared using the chisquare test.
Nonpaired t tests or the Mann-Whitney U test for continuous data and chi-square test for categorical data were used to compare results between patients with and without CAD. Multivariate logistic regression analysis was used to determine the independent parameters associated with CAD, with adjustment for hypertension, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), HbA 1c , smoking, and statin use. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. Factors that were significantly different for patients with and without CAD and common coronary risk factors were entered into multivariate logistic regression analysis. The receiver-operating characteristic curve was created to assess diagnostic performance to predict CAD. All statistical analyses were performed using the IBM SPSS Statistics software (ver. 18; IBM, Somers, New York), and results were considered significant when 2-tailed P values were <.05.
Results

Patient Characteristics
The characteristics of all 191 patients and subgroups by the presence of CAD are shown in Table 1 . The mean level of LDL-C was 112 + 28 mg/dL, and other risk factors were practically controlled. Patients with CAD had low HDL-C levels as compared with those in patients without CAD (P ¼ .009). No other variables showed significant difference between the groups, for example, hypertension (P ¼ .210), LDL-C (P ¼ .923), and smoking (P ¼ .216). Without any history of CAD, only 19.4% patients were treated with statins, and those with antiplatelet agents were 21.6%. The characteristics of CAD of all 191 patients and subgroups (34 patients with TAA, 137 with AAA, and 20 with both TAA and AAA) are shown in Table 2 . The majority (71.7%) was AAA group. Angiographically significant stenosis of coronary arteries was observed in 38.7% of all patients and in 20.6%, 40.9%, and 55.0% of patients with TAA, AAA, and both TAA and AAA, respectively. In all patients with CAD, the involvement of single, double, and triple vessels was 56.8%, 28.4%, and 14.9%, respectively. Similarly, the main type of CAD was single-vessel disease in each subgroup of patients. These lesions were located in the left anterior descending artery (44.9%), left circumflex artery (26.0%), right coronary artery (26.0%), and left main trunk (3.1%). Importantly, 54.1% of the patients with significant CAD underwent coronary revascularization before surgical intervention.
Univariate and Multiple Logistic Regression Analyses
Univariate analyses were performed to evaluate the factors associated with the presence of CAD in patients with aortic aneurysms. In all patients, low HDL-C levels and the presence of AAA were significantly associated with comorbid CAD (P ¼ .009 and P ¼ .038, respectively). Multiple logistic regression analysis indicated that low HDL-C and AAA were independent predictors of CAD (OR, 0.630; 95% CI, 0.443-0.896; P ¼ .010 and OR, 3.331; 95% CI, 1.081-10.261; P ¼ .036, respectively), with adjustment for hypertension, LDL-C levels, HbA 1c levels, smoking, and statin (Table 3) . We also performed subgroup analysis in patients with TAA, but no independent risk factors were observed after adjustment. In a group of patients with AAA, low HDL-C levels were again correlated with CAD (univariate analysis, P ¼ .041), and multiple logistic regression analysis showed that a low HDL-C level was the sole significant predictor of CAD (OR, 0.646; 95% CI, 0.425-0.981; P ¼ .041).
Hypertension, LDL-C levels, LDL-C/HDL-C ratio, triglyceride (TG) levels, HbA 1c levels, and smoking status were not associated with CAD in the AAA subgroup.
Receiver-Operating Characteristic Analysis
The area under the receiver-operating characteristic curve of HDL-C to predict CAD was 0.616 (95% CI, 0.523-0.708, P ¼ .018). The optimal cutoff level of HDL-C was 47.50 mg/dL with the sensitivity and specificity of 54.8% and 62.7%, respectively ( Figure 1) . No other variables were applicable for the receiver-operating characteristic analysis.
Discussion
The prevalence of CAD in our group of 191 patients with aortic aneurysms was 38.7%; a low HDL-C level was an independent and significant predictor of CAD. The CAD was diagnosed predominantly as single-vessel disease (56.8%), and 54.1% of the patients with significant CAD required coronary revascularization before surgical intervention for the aneurysm. In general, the prevalence of CAD is 8.13 to 11.8 per 1000 in the Japanese population 7 ; accordingly, we observed a significantly high incidence of CAD in patients with aortic aneurysms.
Several guidelines state that atherosclerosis can be a common background for CAD and AAA, 8, 9 and the presence of CAD is associated with higher perioperative risk for patients with AAA. 10 In addition, AAAs can be considered as CAD equivalent based on our results. Compared with the incidence of CAD in patients with AAAs, a relatively low incidence of CAD (20.6%) was observed in patients with TAAs. This can be explained in part by the unique mechanism of TAA formation, which has been identified as a remodeling process of the extracellular matrix, for example, dysregulation of transforming growth factor b signaling. 11 The highest prevalence of CAD was observed in patients with both TAA and AAA (55.0%); however, confirmation of this association and description of the detailed pathophysiology warrant a study with a large number of patients.
Previous studies have shown that low HDL-C levels are associated with the presence of CAD independent of the risk estimated using a high LDL-C level. 12, 13 To our knowledge, this is the first study showing the sole association of CAD with low HDL-C levels in patients with aortic aneurysms. The association between low HDL-C levels and advanced cardiovascular risk has been highlighted in patients treated with statin in whom serum LDL-C levels were maintained at <70 mg/dL, in a post hoc analysis of the TNT trial.
14 The Measuring Effects on Intima-Media Thickness: An Evaluation of Rosuvastatin (METEOR) substudy showed that low HDL-C levels are associated with echolucent plaques of the carotid intima-media, suggesting a high risk of cardiovascular events. 15 These studies clearly highlight the critical role of HDL-C in preventing the progression of atherosclerosis. A recent meta-analysis has demonstrated that treatment with statin therapy does not alter the association between low levels of HDL-C and increased cardiovascular risk. 16 Current guidelines recommend statin use in patients undergoing coronary artery bypass grafting 17 ; however, beneficial effects in noncardiac vascular surgery patients have not been fully elucidated. 18 Although we did not have enough data to show a statin effect in patients with aortic aneurysms, we may recommend perioperative statin use as shown in a recent study. 19 The critical importance of HDL-C function as well as HDL-C levels can be explained by HDL-C-mediated efflux of cholesterol from the peripheral arterial wall to the liver, that is, reverse cholesterol transport. 20 This transport has been thought to prevent atherosclerosis in the following ways: macrophage-specific or nonspecific arterial wall efflux, nonarterial wall efflux, lipoprotein transport, hepatic cholesterol uptake, and direct excretion into small intestine or fecal excretion. 21 Efflux capacity was a strong inverse predictor of coronary disease status, independent of the HDL-C level. 22 In addition, decreased cholesterol efflux has been suggested to be a residual risk factor in statin-treated patients with a low HDL-C level. 23 Thus, not only low serum levels but also the dysfunction of HDL-C 24 can be a new target to treat patients with cardiometabolic risk factors and/or atherosclerosis. Further research is required to examine HDL-C function in patients with aortic aneurysms.
Peripheral arterial disease (PAD) is a manifestation of systemic atherosclerosis 3 and is an important predictor of concomitant atherosclerotic diseases. 25 The Reduction of Atherothrombosis for Continued Health (REACH) registry, a worldwide cohort study, showed that almost 30% of the patients with PAD also have CAD. 26 Recent reports have also indicated that PAD is significantly associated with CAD in patients with AAA 27 and that myocardial ischemia is more frequent in patients with combined PAD and an aortic aneurysm (73%) than in those with PAD (55%) only or those with an aortic aneurysm (37%) only. 25 In the current study, however, no correlation was observed between the presence of CAD and the ankle-brachial pressure index, a marker of PAD, probably because of this specific population of patients with aortic aneurysms. No other predictors were identified in our study, which included aspects of patient's medical histories and treatment (eg, statins and antiplatelet agents).
Recent reports have indicated that nonfasting TG levels 28 as well as TG/HDL-C ratios and non-HDL-C levels 29 are also independently correlated with cardiovascular events. In our study, however, the statistically significant factor was a low HDL-C level alone, and no other lipid profile parameter was associated with comorbid CAD with aortic aneurysm. Interestingly, HDL-C has been identified as the most important lipid variable for predicting the risk of AAA development. 8, 30 Low HDL-C levels, therefore, appear to play an important role in the development of AAA as well as in the comorbidity CAD of these patients. Thus, lipid-modifying strategies should be further focused on raising HDL-C levels to reduce cardiovascular events. The clinical benefits of an increase in HDL-C levels have been highlighted in the Framingham Heart Study, where an increase in HDL-C by 1 mg/dL resulted in a 2% to 3% decrease in the incidence of CAD. 31 Mabuchi et al revealed that a 10-mg/dL increase in HDL-C lowered the relative risk of a coronary event by 28.3%. 32 Our study indicated that the reduction in the relative risk of CAD with additional 1 mg/dL decrease in the HDL-C level was 6.3%.
Study Limitations
First, a potential selection bias can be expected in this small cohort study. Second, CAD was angiographically defined and was not identical to actual myocardial ischemia with any findings on myocardial perfusion images. Third, the results of this study may predominantly reflect data from the AAA group because of the predominant number of patients with AAA. Fourth, the rationale for low HDL-C levels being the sole predictor for CAD in this study is unknown, although common risk factors play important roles in the development of cardiovascular disease. Fifth, HDL-C function and cholesterol efflux capacity were not evaluated. Further investigations in large-scale prospective clinical studies and/or basic sciences are necessary to elucidate the roles of HDL-C and its function in the pathophysiological association between CAD and aortic aneurysms.
Although routine preoperative coronary angiography is not strongly recommended for patients with few cardiovascular risks and with functional exertion capacity of >4 metabolic equivalents, 33 this study and previous studies consistently show a high prevalence of CAD, especially in patients with AAA. Accordingly, we encourage clinicians to evaluate CAD intensively in patients with low HDL-C levels, before surgical intervention for aortic aneurysms.
Conclusions
A low HDL-C level was an independent predictor of comorbid CAD in patients with aortic aneurysms. A high prevalence of CAD in patients with aortic aneurysms highlights the importance of surgical risk stratification according to HDL-C levels to identify patients with comorbid CAD.
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